By William A. Hyman – One of the many questions in the design and use of Clinical Decision Support software is whether or not the user can recreate the logic used by the system in reaching its conclusions and recommendations–or alerts, or suggestions.
Read More
By Robert Rowley MD – A recent article by The Commonwealth Fund raises the question of being able to use smartphone apps to get real-time, accurate and personalized guidance for health concerns. While one can envision the convenience, affordability and peace of mind that would result from their use, such services face a number of hurdles before they become reality.
On our next Healthcare De Jure, host Matt Fisher and his guests discuss the use of Artificial Intelligence in patient engagement and care coordination. Join the conversation at #HCdeJure.
By Robert Rowley MD – One of the most frustrating elements of the current healthcare environment is the administrative burden of prior authorizations for medications and procedures. It is a frustration for providers, for patients, and for payers. Is there any way to solve this dilemma?
By Alex Meshkin – We have seen incredible progress in machine learning and artificial intelligence (AI) over the past few years, especially through the application of deep learning algorithms. AI systems will get even better as more data is collected, so faster data gathering and better data integration should lead to smarter and more useful AI systems.
By Robert Rowley MD – Utilization Management (UM) is ubiquitous in healthcare. It is a system of authorizations for procedures and some referrals, for the determination of medical necessity vs. elective, cosmetic or experimental procedures, for determining bed-day allowances in hospitals, and for establishing preferred drug formularies.
By Alex Meshkin – Just over a year ago, in his 2015 State of the Union Address, President Obama announced the Precision Medicine Initiative. During the 2016 State of the Union Address, Obama announced the “Cancer Moonshot” to cure cancer, with Vice President Biden at the helm.
By Sarianne Gruber – VP of IBM Watson Health, Dr. Kathleen McGroddy Goetz is focused on technology and commercialization where “the pace has been very busy”. Kathy has been instrumental in many of new acquisitions and partnerships for IBM Watson Health including Phytel, a population health software, and Softlayer for Cloud Computing.
By Sarianne Gruber – Dr. Kathleen McGroddy Goetz, though she prefers to be called Kathy, describes her career as a journey. A trained academic in healthcare and life sciences with a research perspective, her first aspiration was to do drug discovery.